Quarterly report pursuant to Section 13 or 15(d)

Stock Plans (Tables)

v3.19.3
Stock Plans (Tables)
9 Months Ended
Sep. 30, 2019
Schedule of Stock-based Compensation Expense

The Company’s stock-based compensation expense recognized for the periods presented was as follows:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units

 

$

251

 

 

$

130

 

 

$

748

 

 

$

277

 

Restricted stock awards

 

 

47

 

 

 

59

 

 

 

303

 

 

 

412

 

Machine Box contingent common stock issuances

 

 

28

 

 

 

 

 

 

1,255

 

 

 

 

Performance-based stock options

 

 

2,000

 

 

 

1,846

 

 

 

5,956

 

 

 

1,900

 

Stock options

 

 

2,329

 

 

 

2,575

 

 

 

7,389

 

 

 

6,857

 

Employee stock purchase plan

 

 

109

 

 

 

228

 

 

 

398

 

 

 

517

 

Total

 

$

4,764

 

 

$

4,838

 

 

$

16,049

 

 

$

9,963

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Stock-based compensation expense by operating expense grouping:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

$

281

 

 

$

246

 

 

$

795

 

 

$

814

 

Research and development

 

 

334

 

 

 

596

 

 

 

2,318

 

 

 

1,103

 

General and administrative

 

 

4,149

 

 

 

3,996

 

 

 

12,936

 

 

 

8,046

 

 

 

$

4,764

 

 

$

4,838

 

 

$

16,049

 

 

$

9,963

 

Schedule of Restricted Stock Award Activity

The Company’s restricted stock award activity for the nine months ended September 30, 2019 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2018

 

 

72,208

 

 

$

7.26

 

Vested

 

 

(36,982

)

 

$

7.03

 

Unvested at September 30, 2019

 

 

35,226

 

 

$

7.50

 

Schedule of Restricted Stock Unit Activity

The Company’s restricted stock unit activity for the nine months ended September 30, 2019 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2018

 

 

49,143

 

 

$

12.57

 

Granted

 

 

150,211

 

 

$

7.28

 

Forfeited

 

 

(7,300

)

 

$

8.81

 

Vested

 

 

(50,009

)

 

$

12.51

 

Unvested at September 30, 2019

 

 

142,045

 

 

$

7.20

 

 

Schedule of Stock Option Activity

The activity during the nine months ended September 30, 2019 related to all other stock options was as follows:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2018

 

 

5,154,691

 

 

$

13.78

 

 

 

 

 

 

 

Granted

 

 

607,596

 

 

$

5.86

 

 

 

 

 

 

 

Exercised

 

 

(53,162

)

 

$

3.10

 

 

 

 

 

 

 

Forfeited

 

 

(288,429

)

 

$

11.15

 

 

 

 

 

 

 

Expired

 

 

(91,025

)

 

$

13.81

 

 

 

 

 

 

 

Outstanding at September 30, 2019

 

 

5,329,671

 

 

$

13.13

 

 

7.83 years

 

$

546

 

Exercisable at September 30, 2019

 

 

3,552,793

 

 

$

13.91

 

 

7.46 years

 

$

541

 

Employee Stock Purchase Plan [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the nine months ended September 30, 2019 are set forth in the table below:

 

Expected term (in years)

 

0.5 - 2.0

 

Expected volatility

 

51% - 71%

 

Risk-free interest rate

 

1.3% - 2.5%

 

Expected dividend yield

 

 

 

Timebased Stock Option [Member]  
Schedule of Fair Value Assumptions The following assumptions were used to compute the grant date fair values of the Time-Based Options granted during the nine months ended September 30, 2019:

Expected term (in years)

 

 

 

6.0 - 6.1

 

Expected volatility

 

 

 

66% - 68%

 

Risk-free interest rate

 

 

 

1.5% - 2.5%

 

Expected dividend yield

 

 

 

 

 

 

Performance-based Stock Options [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan The following assumptions were used in the Monte Carlo simulation model for computing the grant date fair values of the Performance Options granted during the nine months ended September 30, 2019:

Estimated volatility

 

 

65

%

Risk-free interest rate

 

 

2.7

%

Dividend yield

 

 

%

Cost of equity

 

 

14

%

 

Schedule of Stock Option Activity

The activity during the nine months ended September 30, 2019 related to stock options that are subject to performance-based vesting conditions tied to the future achievement of stock price goals by the Company was as follows:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

 

Value

 

Outstanding at December 31, 2018

 

 

3,167,325

 

 

$

21.25

 

 

 

 

 

 

 

 

 

Granted

 

 

1,619,175

 

 

$

5.69

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(216,477

)

 

$

5.66

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2019

 

 

4,570,023

 

 

$

16.48

 

 

8.86 years

 

 

$

 

Exercisable at September 30, 2019

 

 

 

 

$

 

 

 

 

 

$